Extremely significant negative changes in Cross Country Healthcare Inc (NASDAQ: CCRN) fundamentals have recently occurred: the stock’s power rating fell below 50, significant quarterly earnings deceleration occurred, the consensus estimate for December, 2024 decreased significantly, significant quarterly sales deceleration occurred, and the consensus estimate for December, 2023 decreased significantly.
In light of these highly negative signals we are reviewing our current Overall Rating of C. We would view the shares with caution pending completion of this review in the next several days.
Current PriceTarget Research Rating
With future capital returns forecasted to be in line with the cost of capital, CCRN is expected to be Value Creation neutral.
Cross Country Healthcare has a current Value Trend Rating of C (Neutral). This rating combines consistent signals from two proprietary PTR measures of a stock’s attractiveness. Cross Country Healthcare has a slightly positive Appreciation Score of 70 and a neutral Power Rating of 43, leading to the Neutral Value Trend Rating.
Recent Price Action
Cross Country Healthcare Inc (NASDAQ: CCRN) stock closed at $17.94 on 11/13/23 after a decline of -2.0%. The stock has declined -7.4% during the last week and has performed in line with the market over the last nine months.
Be the first to comment